SELF-SCREEN
The history of Self-screen is a track record in translational science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of cancer screening into routine practice. Our dedication is towards the development and clinical application of molecular assays for the early detection of cancer, thereby to the benefit of patients around the world. Currently, the company’s main focus is on cervical cancer screening and prevention. The company has two cli... nically validated assays on the market. We strive towards all-molecular screening to ensure objectivity, reproducibility and high-throughput possibilities. Our research and development pipeline currently focuses on the extension of our science towards other sample types, like urine, and towards other cancer types.
SELF-SCREEN
Industry:
Biotechnology Health Diagnostics Life Science Medical
Founded:
2008-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.self-screen.nl
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.26 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Self-screen
Official Site Inspections
http://www.self-screen.nl
- Host name: lsw.solcon.nl
- IP address: 212.45.63.20
- Location: Ambt Delden Netherlands
- Latitude: 52.2611
- Longitude: 6.668
- Timezone: Europe/Amsterdam
- Postal: 7495
More informations about "Self-screen"
Home - Self-screen
Self-screen's main focus is on cervical cancer screening and prevention. The company has two clinically validated assays on the market. We strive towards all-molecular screening to ensure …See details»
Our company – Self-Screen
This site requires JavaScript to render the code.Need to know how to enable JavaScript? Go here.See details»
Self-screen - Crunchbase Company Profile & Funding
The history of Self-screen is a track record in translational science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of cancer screening …See details»
What we do – Self-Screen
Currently, the company’s main focus is on cervical (pre)cancer screening and prevention. Self-screen has two clinically validated molecular assays on the market. We strive towards full-molecular screening to ensure sensitivity, …See details»
Self-Screen | Lifesciences @ Work
The history of Self-screen is a track record in translational science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of cancer screening into routine practice. Our dedication is towards …See details»
Self-screen B.V.: Contact Details and Business Profile
Self-screen B.V. is a Biotechnology Research, Business Services General, and Health Diagnostics company_reader located in Amsterdam, North Holland with $5 million in revenue …See details»
Self-screen B.V. | Amsterdam [TransFirm]
De Onderneming Self-screen B.V., geregistreerd bij de Kamer van Koophandel (KvK) onder nummer 34292236, is gevestigd aan de Biothof 15-1 in Amsterdam (postcode 1098 RX).Self …See details»
Self-screen B.V. Company Profile | Amsterdam, Noord-Holland ...
Find company research, competitor information, contact details & financial data for Self-screen B.V. of Amsterdam, Noord-Holland. Get the latest business insights from Dun & Bradstreet.See details»
Self-screen BV - Laboratorium.nl
Self-screen richt zich op de ontwikkeling, productie en uitvoer van laboratoriumtesten voor accurate, vroege opsporing van kanker. Met vroege detectie en behandeling van de …See details»
Self-screen - explore.openaire.eu
Partners: Self-screen With an estimated 528,000 new cases and 266,000 deaths in 2012, cervical cancer (CC) is the fourth most common type of cancer in women, and the seventh overall.See details»
RISCC Self-screen B.V.
Self-screen (founded in 2008 as a spin-off company from the VU University Medical Center, Amsterdam, the Netherlands) is a leading authority in Europe on cervical cancer research and …See details»
Self-screen - Products, Competitors, Financials, Employees ...
Self-screen primarily serves the healthcare industry, focusing on cervical cancer screening and prevention through self-sampling methodologies and diagnostic testing. It was founded in 2008 …See details»
Michelle Meijer posted on LinkedIn
Welcome Michelle Meijer and the rest of the Self-screen B.V. team! We are happy to support you and hope that great innovations will grow from your new labspace at the Health & Innovation …See details»
Self-screen - Overview, News & Competitors | ZoomInfo.com
View Self-screen (www.self-screen.nl) location in North Holland, Netherlands , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Our offering – Self-Screen
Current projects: Self-screen has acquired a prestigious SME Instrument grant in the Horizon 2020 program from the European Commission. In the project, named Valid-screen, a large …See details»
Self-screen B.V. Overview | SignalHire Company Profile
The history of Self-screen is a track record in translational science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of cancer screening …See details»
Self-screen B.V. - CMOCRO
Self-screen B.V. designs, develops and validates tests for the detection, screening of (pre)cancer and monitoring of patients after (pre)cancer treatment. Self-screen\'s experience and focus is …See details»
Our science – Self-Screen
Our science focuses on early cervical cancer detection. Worldwide, cervical cancer is the fourth most common malignancy in women, and the seventh overall, with an estimated 528,000 new …See details»
NL government adds cancer self-screening to MyHealthNL app
3 days ago The NL government is making strides in addressing its deficiencies when it comes to cancer screenings. It was only a couple of months ago when the age to screen for breast …See details»
HPV-Risk Assay – Self-Screen
The HPV-Risk Assay is an in vitro real-time PCR-based assay for the qualitative detection of human papillomavirus (HPV) DNA, targeting the E7 region of the following 15 (probably) high …See details»